brello health glp-1 About Brello Health has really been

Purpose This meta-analysis aimed to evaluate the pooled efficacy of GLP-1 RAs on sleep-disordered breathing, body weight, and cardiovascular risk factors in patients with OSA

These drugs help manage insulin resistance, weight, and hormonal imbalances

GLP-1 Receptor Activation Mechanism Increases insulin secretion in response to glucose, preventing blood sugar spikes Reduces glucagon production, stabilizing blood sugar levels Slows gastric emptying, helping patients feel fuller for longer Regulates appetite and reduces cravings, leading to lower caloric intake Supports long-term fat loss and metabolic stability By addressing multiple metabolic pathways, Semaglutide supports sustainable weight management and improved glucose control

Wegovy Results In the course of 68 weeks, the patients who used Wegovy at a maintenance dose of 2.4 mg per day lost approximately 15 percent of their initial body weight on average

Therefore, the management strategies of smaller meals, hydration, and careful titration are universal